Phoreus Biotech is driving scientific innovation through superior nanocarrier technology
Phoreus Biotech is a life sciences startup founded in 2018 and based in the Kansas City metro area. A discovery of Kansas State University, our Branched Amphipathic Peptide Capsules (BAPC®️) represent an entirely new class of nanocarrier technology. Even though our work is on the nanoscale, it doesn’t mean we aren’t focusing on the big picture. We believe our technology has the capacity to transform the global landscape of human, animal, plant and environmental health.
The problem with some nanocarriers
For too long now, research with nanoparticles has always required some level of tradeoff. A nanocarrier might transfect efficiently but be highly toxic to cells. Others might not cause an immune response but, due to their lack of biodegradability, build up in the environment over time. BAPC®️ not only overcome all the issues of existing nanocarriers but offer a level of customization that make them the superior choice for virtually any application.
Better delivery means better results
Successful results in the lab don’t always immediately translate well to commercially viable applications. Without an effective method of delivery, the full potential of new discoveries may never be realized. Our mission at Phoreus is to transform innovative new discoveries into tangible products that make a difference in people’s lives. This is why BAPC®️-assisted technology is already in use by government, commercial and academic scientists around the world.
Meet our leadership team below.